Sumitomo Mitsui Trust Group
BNTX icon

Sumitomo Mitsui Trust Group’s BioNTech BNTX Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-32,214
Closed -$3M – 1070
2026
Q2 		$3M Sell
32,214
-45,480
-59% -$4.28M ﹤0.01% 775
2026
Q1 		$6.91M Buy
+77,694
New +$7.98M ﹤0.01% 697

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Davern Capital Partners
Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Sumitomo Mitsui Trust Group's BNTX Position: Q3 2026 in Review

Sumitomo Mitsui Trust Group sold out of BioNTech (BNTX) in Q3 2026, closing a stake of 32,214 shares — an estimated $3M sold.

Sumitomo Mitsui Trust Group first reported a position in BNTX in Q1 2026 and held it in 2 quarters. The position peaked at $6.91M in Q1 2026. 202 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Sumitomo Mitsui Trust Group reported no remaining BioNTech position as of Q3 2026 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 32,214 BioNTech shares in Q3 2026, an estimated $3M.
  • Sumitomo Mitsui Trust Group first reported a position in BioNTech in Q1 2026 and held it in 2 quarters.
  • Sumitomo Mitsui Trust Group's BioNTech position peaked at $6.91M in Q1 2026.
  • 202 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2026, filed 29 Oct 2026.